July 14, 2017 News by Joana Fernandes, PhD Breastfeeding May Be Linked to Reduced Risk of MS, Study Suggests Women who breastfeed for 15 months or longer may have a lower risk of developing multiple sclerosis (MS) than those who breastfeed for shorter periods or not at all, according to a recent study. The study also suggests that women who had their first…
May 10, 2017 News by Joana Fernandes, PhD Exposure to Sunlight During Pregnancy Has No Influence on MS Risk in Children, Polish Study Finds The risk of childrenĀ developingĀ multiple sclerosis (MS) later in life has no link to how much sunlight their mothers were exposed to during pregnancy, a Polish study found. The study, āMonth of birth and level of insolation as risk factors for multiple sclerosis in Poland,ā appeared in the journal…
May 8, 2017 News by Joana Fernandes, PhD Pregnant Women with Relapsing MS Can Use Copaxone Without Harming Baby, Study Indicates Babies of women with relapsing multiple sclerosis (RMS) who receive daily injections ofĀ Copaxone (glatiramer acetate) while pregnant carry the same risk of developing birth defects as babies as a whole, according to a study by the therapy’s developer,Ā Teva Pharmaceutical Industries. The findings can help doctors counsel and treat…
April 3, 2017 News by Patricia Silva, PhD What Every MS Patient Should Know About Ocrevus and Its Use With the recent approval of Ocrevus (ocrelizumab) for both primary progressive and relapsing multiple sclerosis (MS), interest in the medication is peaking.Ā To helpĀ readers of Multiple Sclerosis News TodayĀ better understandĀ this new medication and how it works, as well issues dealingĀ with access, use, and potential side effects, here is aĀ summary…
December 7, 2016 News by Patricia Silva, PhD Copaxone Use During Pregnancy by RMS Patients Now Possible in EU European users ofĀ Copaxone (glatiramer acetate injection, Teva Pharmaceutical) to treatĀ relapsing forms of multiple sclerosis (RMS) will no longer see a warning that the drug should not be used during pregnancy. A report assessing this change in the drug’sĀ marketing authorization within the European Union ā a process known as…
March 8, 2016 News by Patricia Silva, PhD MS Risk Linked to Mothers with Vitamin D Deficiency in First Trimester of Pregnancy Children whose mothers were vitamin D deficient during the early stages of pregnancy are at an elevated risk for developing multiple sclerosis (MS) in adulthood, according to a study published in the journal JAMA Neurology,Ā titled āVitamin D Status During Pregnancy and Risk of Multiple…
March 1, 2016 News by admin MS Progression Apparently Not Affected by Number of Pregnancies, Study Reports New long-term research indicates that having multiple children does not lessen or otherwise impact disability in women with multiple sclerosis (MS).Ā The study, titled “Offspring Number Does Not Influence Reaching the Disabilityās Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study,“Ā was published in The International Journal…
September 18, 2015 News by Patricia Silva, PhD Pregnancy-Associated Issues in Multiple Sclerosis Patients Highlighted in New Review A study recently published in the European Journal of Neurology reviewed some of the issues associated with pregnancy in multiple sclerosis (MS) patients. The study is entitled āAn overview of pregnancy-related issues in patients with multiple sclerosisā and was developed by researchers at Sapienza…
June 22, 2015 News by Patricia Silva, PhD Study Shows Vitamin D Supplementation in Pregnant Women With MS Positively Impacts Disease Severity In women of childbearing age, low vitamin D levels are a common issue often resulting from low intake of vitamin D (in food) and/or inadequate sunlight exposure, although other less frequent causes exist, including genetic disorders and pregnancy. The mostĀ identified consequence of vitamin D deficiency in women is sub-optimal bone…